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Expression of mucoid induction factor MucE is
dependent upon the alternate sigma factor AlgU
in Pseudomonas aeruginosa
Yeshi Yin1,3, F Heath Damron1,7, T Ryan Withers1, Christopher L Pritchett5,6, Xin Wang3, Michael J Schurr5
and Hongwei D Yu1,2,4*

Abstract
Background: Alginate overproduction in P. aeruginosa, also referred to as mucoidy, is a poor prognostic marker for
patients with cystic fibrosis (CF). We previously reported the construction of a unique mucoid strain which overexpresses
a small envelope protein MucE leading to activation of the protease AlgW. AlgW then degrades the anti-sigma factor
MucA thus releasing the alternative sigma factor AlgU/T (σ22) to initiate transcription of the alginate biosynthetic operon.
Results: In the current study, we mapped the mucE transcriptional start site, and determined that PmucE activity was
dependent on AlgU. Additionally, the presence of triclosan and sodium dodecyl sulfate was shown to cause an increase
in PmucE activity. It was observed that mucE-mediated mucoidy in CF isolates was dependent on both the size of MucA
and the genotype of algU. We also performed shotgun proteomic analysis with cell lysates from the strains PAO1, VE2
(PAO1 with constitutive expression of mucE) and VE2ΔalgU (VE2 with in-frame deletion of algU). As a result, we
identified nine algU-dependent and two algU-independent proteins that were affected by overexpression of MucE.
Conclusions: Our data indicates there is a positive feedback regulation between MucE and AlgU. Furthermore, it seems
likely that MucE may be part of the signal transduction system that senses certain types of cell wall stress to P. aeruginosa.
Keywords: Pseudomonas aeruginosa, Alginate, Mucoidy, AlgU/T, MucE, Sigma factor

Background
P. aeruginosa, a Gram-negative bacterium, is the leading
cause of morbidity and mortality in patients with cystic
fibrosis (CF) [1]. In CF, P. aeruginosa is often isolated
from sputum samples and exhibits a phenotype called
mucoidy, which is due to overproduction of an exopolysaccharide called alginate. It is also an environmental
bacterium which normally does not overproduce alginate
[2]. The emergence of mucoid P. aeruginosa isolates in
CF sputum specimens signifies the onset of chronic respiratory infections. Mucoidy plays an important role in
the pathogenesis of P. aeruginosa infections in CF, which
includes, but is not limited to: increased resistance to
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antibiotics [1], increased resistance to phagocytic killing
[3,4] and assistance in evading the host’s immune response [3].
A major pathway for the conversion to mucoidy in P.
aeruginosa is dependent upon AlgU (AlgT, σ22), an alternative sigma factor that drives transcription of algD encoding the key enzyme for alginate biosynthesis [5,6].
Previous studies have shown that several genes take part
in the regulation of AlgU activation and alginate overproduction. MucA is a trans-membrane protein that
negatively regulates mucoidy by acting as an anti-sigma
factor via sequestering AlgU to the cytoplasmic membrane [7]; MucB and intra-membrane proteases AlgW,
MucP and ClpXP were reported to affect alginate production by affecting the stability of MucA [8]. A small
envelope protein called MucE was found to be a positive
regulator for mucoid conversion in P. aeruginosa strains
with a wild type MucA [9]. The mechanism for mucE induced mucoidy is due to its C-terminal –WVF signal,
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which can activate the protease AlgW possibly by interaction with the PDZ domain [9]. Upon activation, AlgW
initiates the proteolytic degradation of the periplasmic
portion of MucA, causing the release of AlgU to drive
expression of the alginate biosynthetic operon [9]. While
the function of MucE as an alginate inducer was identified, its physiological role, and its role in the regulation
of mucoidy in clinical isolates, remains unknown.
Comparative analysis through Basic Local Alignment
Search Tool (BLAST) using the genomes of Pseudomonas species from the public databases reveals that
MucE orthologues are found only in the strains of P.
aeruginosa [9]. In order to study the role and regulation
of MucE in P. aeruginosa, we first mapped the mucE
transcriptional start site. We then examined the effect of
five different sigma factors on the expression of mucE
in vivo. Different cell wall stress agents were tested for
the induction of mucE transcription. Expression of
MucE was also analyzed in non-mucoid CF isolates to
determine its ability to induce alginate overproduction.

Methods
Bacteria strains, plasmids, and growth conditions

Bacterial strains and plasmids used in this study are
shown in Additional file 1: Table S1. E. coli strains were
grown at 37°C in Luria broth (LB, Tryptone 10 g/L,
Yeast extract 5 g/L and sodium chloride 5 g/L) or LB
agar. P. aeruginosa strains were grown at 37°C in LB or
on Pseudomonas isolation agar (PIA) plates (Difco).
When required, carbenicillin, tetracycline or gentamicin
were added to the growth media. The concentration of
carbenicillin, tetracycline or gentamycin was added at
the following concentrations: for LB broth or plates
100 μg ml-1, 20 μg ml-1 or 15 μg ml-1, respectively. The
concentration of carbenicillin, tetracycline or gentamycin
to the PIA plates was 300 μg ml-1, 200 μg ml-1 or 200 μg
ml-1, respectively.
The mucE primer extension assay

Total RNA was isolated from P. aeruginosa PAO1 grown
to an OD600 of 0.6 in 100 ml LB at 37°C as previously
described [10]. The total RNA was isolated using the
RNeasy kit (Qiagen, Valencia, CA) per the manufacturer’s instructions. Primers for mucE (PA4033), seq 1
(5′-CCA TGG CTA CGA CTC CTT GAT AG-3′) and
seq 2 (5′-CAA GGG CTG GTC GCG ACC AG-3′),
were radio-labeled using T4 polynucleotide kinase (New
England Biolabs, Ipswich, MA) and γP32-ATP. Primer
extensions were performed using the Thermoscript RTPCR system (Invitrogen, Carlsbad, CA) with either
PA4033 seq 1 or seq 2 with 10–20 μg of total RNA. Extensions were performed at 55°C for an hour. Primer extension products then were electrophoresed through a
6% acrylamide/8M urea gel along with sequencing
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reactions (Sequenase 2.0 kit, USB, Cleveland, OH) using
the same primers used in the extension reactions.
Transformation and conjugation

E. coli One Shot TOP10 cells (Invitrogen) were transformed via standard heat shock method according to the
supplier’s instructions. Plasmid transfer from E. coli to
Pseudomonas was performed via triparental conjugations
using the helper plasmid pRK2013 [11].
Generating PAO1 miniCTX-PmucE-lacZ reporter strain

PAO1 genomic DNA was used as a template to amply
618 bp upstream of the start site (ATG) of mucE using
two primers with built-in restriction sites, HindIIImucE-P-F (5′-AAA GCT TGG TCG TTG AAA GTC
TGC ACC TCA-3′) and EcoRI-mucE-P-R: (5′-CGA
ATT CGG TTG ATG TCA CGC AAA CGT TGG C-3′).
The PmucE amplicon was TOPO cloned and digested with
HindIII and EcoRI restriction enzymes before ligating
into the promoterless Pseudomonas integration vector
miniCTX-lacZ. The promoter fusion construct miniCTXPmucE-lacZ was integrated onto the P. aeruginosa chromosome of strain PAO1 at the CTX phage att site [12]
following triparental conjugation with E. coli containing
the pRK2013 helper plasmid [11].
Screening for a panel of chemical agents that can
promote PmucE transcription

Membrane disrupters and antibiotics were first tested
by serial dilution to determine the minimum inhibitory concentration (MIC) for strain PAO1::attB::
PmucE-lacZ. An arbitrary sub-MIC concentration for
each compound was then tested for the induction
effect through the color change of 5-Bromo-4-chloro3-indolyl β-D-galactopyranoside (X-gal, diluted in
dimethylformamide to a concentration of 4% (w/v)). The
final concentration of the compounds used in this study
are listed as follows: triclosan 25 μg/ml, tween-20 0.20%
(v/v), hydrogen peroxide 0.15%, sodium hypochlorite
0.03%, SDS 0.10%, ceftazidimine 2.5 μg/ml, tobramycin
2.5 μg/ml, gentamicin 2.5 μg/ml, colisitin 2.5 μg/ml, and
amikacin 2.5 μg/ml. PAO1::attB::PmucE-lacZ was cultured
overnight in 2 ml LB broth, 10 μl of overnight culture
and 10 μl of 4% X-gal was added to each treatment culture tube (2 ml LB broth + cell wall stress agent). The
cultures were grown overnight at 37°C with shaking at
150 rpm and were used to visually observe the change of
the color. LB broth lacking X-gal was used as a negative
control.
The β-galactosidase activity assay

Pseudomonas strains were cultured at 37°C on three PIA
plates. After 24 hours, bacterial cells were harvested and
re-suspended in PBS. The OD600 was measured and
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adjusted to approximately 0.3. Cells were then permeabilized using toluene, and β-galactosidase activity was
measured at OD420 and OD550. The results in Miller Units
were calculated according to this formula: Miller Units =
1000 × [OD420 - (1.75 × OD550)]/[Reaction time (minutes) ×
Volume (ml) × OD600] [13]. The reported values represent
an average of three independent experiments with standard error.
Alginate assay

P. aeruginosa strains were grown at 37°C on PIA plates
in triplicate for 24 hrs or 48 hrs. The bacteria were collected and re-suspended in PBS. The OD600 was analyzed for the amount of uronic acid in comparison with
a standard curve made with D-mannuronic acid lactone
(Sigma-Aldrich), as previously described [14].
iTRAQ® MALDI TOF/TOF proteome analysis

Strains PAO1, VE2 and VE2ΔalgU were cultured on PIA
plates for 24 hrs at 37°C. Protein preparation and iTRAQ
mass spectrometry analysis was performed according to
previously described methods [15].

Results
Mapping of the mucE promoter in PAO1

We previously identified MucE, a small envelope protein, which induces mucoid conversion in P. aeruginosa
when overexpressed [9]. Induction of MucE activates the
intramembrane protease AlgW resulting in activation of
the cytoplasmic sigma factor AlgU and conversion from
nonmucoidy to mucoidy in strains with a wild type
MucA [9]. Stable production of copious amounts of alginate is characteristic of strain VE2 which carries a
mariner transposon insertion before mucE [9]. This insertion is likely responsible for the constitutive expression of the mucE gene [9]. However, it is unclear how
mucE is naturally expressed in parent PAO1. To determine this, primer extension analysis of the mucE promoter region was performed. With higher amounts of
PAO1 RNA (20 μg), we observed one prominent transcriptional start site that is initiated 88 nucleotides upstream of the mucE translational start site (Figure 1).
This suggests that, under these conditions, mucE has
one promoter that is active in PAO1.
The alternative sigma factor AlgU activates transcription
of mucE in vivo

In order to determine which sigma factor is responsible
for driving mucE transcription, miniCTX-PmucE-lacZ
was integrated onto the PAO1 chromosome. To identify
the sigma factor that activates the expression of PmucE, we
expressed P. aeruginosa sigma factors (RpoD, RpoN,
RpoS, RpoF and AlgU) in trans and measured PmucE-lacZ
activity in this PAO1 fusion strain. As seen in Figure 2,

Page 3 of 11

Miller assay results showed that AlgU significantly increased the promoter activity of PmucE in PAO1. However, we did not observe any significant increases in
promoter activity of PmucE with other sigma factors tested
in this study. As stated earlier, AlgU is a sigma factor
that controls the promoter of the alginate biosynthetic
gene algD [5,6]. In order to determine whether the activity of PmucE is elevated in mucoid strains, pLP170-PmucE
was conjugated into mucoid laboratory and clinical P.
aeruginosa strains. As seen in Figures 3A and 3B, the activity of PmucE increased in mucoid laboratory and CF
isolates.
Cell wall stress promotes expression of mucE from PmucE

Since the mucE promoter was active in nonmucoid
PAO1 and further increased in mucoid cells (Figure 3A),
the conditions that induce mucE expression were examined. To do this, we used the same PmucE-lacZ strain of
PAO1 to measure the activation of mucE by some compounds previously shown to cause cell wall perturbations [17,18]. The phenotypes of strains harboring the
PmucE-lacZ fusion in the presence of various cell wall
stress agents are shown in Figure 4A. While sodium
hypochlorite and colistin didn’t induce a visual change
in PmucE activity, three compounds, triclosan, sodium
dodecyl sulfate (SDS) and ceftazidime induced marked
expression of PmucE-lacZ in PAO1. Each resulted in elevated levels of β-galactosidase activity as indicated by
the blue color of the growth media. This suggests that
the PmucE promoter activity was increased in response to
these stimuli (Figure 4A). Miller assays were performed
to measure the changes in PmucE-lacZ activity due to
these compounds. Triclosan increased PmucE-lacZ activity by almost 3-fold over LB alone (Figure 4B). An increase in PmucE-lacZ should increase PalgU-lacZ activity.
As expected, triclosan caused a 5-fold increase in PalgUlacZ activity. However, SDS and ceftazidime increased
the PmucE-lacZ activity, but did not promote the PalgUlacZ activity (Figure 4B).
Alginate production is reduced in the mucE mutant
compared to PAO1

Expression of mucE can cause alginate overproduction
[9]. However, we wondered if mucE would affect transcriptional activity at PalgU and PalgD promoters. In order
to determine this, both pLP170-PalgU and pLP170-PalgD
with each promoter fused to a promoterless lacZ gene
were conjugated into PAO1 and PAO1VE2, respectively.
As seen in Additional file 1: Figure S1, the activity of
PalgU (PAO1VE2 vs. PAO1: 183,612.04 ± 715.23 vs. 56.34 ±
9.68 Miller units) and PalgD (PAO1VE2 vs PAO1:
760,637.8 ± 16.87 vs. 138.18 ± 9.68 Miller units) was significantly increased in the mucE over-expressed strain
PAO1VE2. Although, Qiu et al. [9] have reported that
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Figure 1 Mapping of the mucE transcriptional start site in P. aeruginosa PAO1. A) Primer extension mapping of mRNA 5′ end. Total RNA was
isolated from the non-mucoid PAO1. The conditions used for labelling of primers for mucE are described in Methods. The primer extension product
was run adjacent to the sequencing ladder generated with the same primer as highlighted in the mucE sequence. The arrow indicates the position of
the P1 transcriptional start site of mucE. B) The mucE promoter sequence in strains PAO1 and PAO1VE2. The transposon (Tn) insertion site of PAO1VE2
is underlined along with the putative ribosome binding site (RBS) for mucE. In strain PAO1VE2, the gentamicin resistance cassette (aacC1) gene carries
a σ70 dependent promoter. The arrow pointing leftward corresponds to the position of primer seq 1 used for mapping the P1 start site.

AlgU is required for MucE induced mucoidy, we wanted
to know whether MucE is required for AlgU induced
mucoidy. As seen in Additional file 1: Figure S2, we did
not observe that the over-expression of MucE induced
mucoidy in PAO1ΔalgU. This result is consistent with
what was previously reported by Qiu et al. [9]. However,
the alginate production induced by AlgU was decreased in the mucE knockout strain. The alginate
production induced by AlgU in two isogenic strains,
PAO1 and PAO1mucE::ISphoA/hah is 224.00 ± 7.35
and 132.81 ± 2.66 μg/ml/OD600, respectively (Additional
file 1: Figure S2). These results indicate that alginate
overproduction in PAO1 does not require MucE. However, MucE can promote the activity of AlgU resulting
in a higher level of alginate production in PAO1 compared to the mucE knockout. Previously, Boucher
et al. [19] and Suh et al. [20] have reported that sigma
factors RpoN and RpoS were involved in alginate

regulation. In order to determine whether mucE induced mucoidy was also dependent on other sigma factors besides AlgU, pHERD20T-mucE was conjugated and
over-expressed in PAO1ΔrpoN, PAO1rpoS::ISlacZ/hah and
PAO1rpoF::ISphoA/hah. The results showed that the
mucE induction caused mucoid conversion in PAO1rpoS::
ISlacZ/hah and PAO1rpoF::ISphoA/hah when 0.1%
L-arabinose was added to the media. However, 0.5%
L-arabinose was required for mucoid conversion in
PAO1ΔrpoN. The alginate production induced by MucE
in PAO1rpoS::ISlacZ/hah, PAO1rpoF::ISphoA/hah and
PAO1ΔrpoN is 150.62 ± 5.27, 85.53 ± 4.10 and 31.84 ±
0.25 μg/ml/OD600, respectively. These results suggested
that RpoN, RpoS and RpoF are not required for MucEinduced mucoidy in PAO1. Conversely, over-expression
of these sigma factors rpoD, rpoN, rpoS and rpoF did
not induce mucoid conversion in PAO1. When the
strains of PAO1 with sigma factor overexpression were
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Figure 2 Effect of overexpression of sigma factors on the PmucE expression. The sigma factors AlgU, RpoD, RpoN, RpoS and RpoF were
expressed from an arabinose-inducible promoter in pHERD20T [16], and the PmucE activity was determined via β-galactosidase assay from a
merodiploid strain of PAO1 carrying PmucE-lacZ integrated on the chromosome. The values reported in this figure represent an average of three
independent experiments with standard error.

measured for alginate production, the level is as follows:
5.11 ± 1.25 (+rpoD), 13.07 ± 4.16 (+rpoN), 3.50 ± 0.10
(+rpoS) and 7.68 ± 1.23 (+rpoF) μg/ml/OD600.
MucE-induced mucoidy in clinical CF isolates is based on
two factors, size of MucA and genotype of algU

Although, Qiu et al. [9] have reported that overexpression of mucE can induce mucoidy in laboratory
strains PAO1 and PA14, its ability to induce mucoidy in
clinical CF isolates has not been investigated. Particularly, mucE’s relationship to mucA mutations is unknown since different mutations would result in
production of MucA with various molecular masses. To
test if the length of MucA had an effect on MucEmediated mucoid induction, we selected a group of
nonmucoid clinical isolates and observed any phenotypic
change after overexpression of mucE. Figure 5 summarizes the results. First, strains with wild type AlgU and
MucA became mucoid. Although, MucA of CF2 carries a
missense mutation, CF2 became mucoid. Secondly, as
seen in Figure 5 and Additional file 1: Table S2, mucE
could induce mucoidy in CF17 (MucA143 + 3 aa) and
CF4349 (MucA125 + 3 aa) with wild type AlgU, but not in
strains containing algU carrying a missense mutation
[CF14 (MucA143 + 3 aa), FRD2 (MucA143 + 3 aa) and CF149
(MucA125 + 3 aa)]. Thirdly, overexpression of mucE did not
induce mucoidy in CF11 and CF28, whose MucA length
was 117aa, despite a wild type AlgU in CF11. These results
suggest that MucE-mediated mucoidy is dependent on the
combination of two factors, MucA length and algU

genotype (Figure 5). The effect of MucE on mucoid induction is more obvious in strains with MucA length up to
125 amino acid residues coupled with wild type AlgU, but
missense mutations in AlgU can significantly reduce the
potency of MucE.
Mutant AlgUs display partial activity resulting in
decreased amount of alginate

Schurr et al. have reported that second-site suppressor mutations in algU can affect mucoidy [21].
DeVries and Ohman [22] also reported that mucoidto-nonmucoid conversion in alginate-producing P.
aeruginosa is often due to spontaneous mutations in
algT (algU). Recently, Damkiaer et al. [23] showed
that point mutations can result in a partially active
AlgU. To test whether the activity of AlgU from different CF isolates is affected due to mutation, the
CF149 and CF28 algU genes were cloned and overexpressed in PAO1ΔalgU and PAO1miniCTX-PalgD-lacZ,
respectively. As seen in Figure 6, these constructs
retained the ability to promote the transcription of PalgD
and alginate production. Also, when transposon libraries
were screened for mucoid revertants in CF149 [24] and
FRD2, three and five mucoid mutants in CF149 and
FRD2, respectively, were identified due to transposon insertion before algU causing the overexpression of algU
(data not shown). However, the activity of the mutant
AlgU is lower than that of wild type AlgU (Figure 6). In
order to determine whether the mutant AlgU still has
the ability to promote mucE transcription, algU genes
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Figure 3 Correlation between the PmucE activity and alginate overproduction in various strains of P. aeruginosa. A) Measurement of the
PmucE activity in various mucoid laboratory and clinical strains. B) Measurement of alginate production (μg/ml/OD600) by the same set of strains as
in A grown on PlA plates without carbenicillin for 24 h at 37°C. The algU(WT)-PAO1 represents the PAO1 strain contained the pHERD20T-algU
(WT). The values reported in this figure represent an average of three independent experiments with standard error.

from CF149 and CF28 were cloned into pHERD20T, respectively, and over-expressed in PAO1 miniCTX-PmucElacZ strain. As seen in Figure 2, mutant forms of AlgU
were still able to promote mucE transcription, albeit at a
reduced level.
Characterization of the MucE regulon using iTRAQ analysis

In order to determine the effect of mucE expression on
the proteome change, we performed iTRAQ proteome
analysis via MALDI TOF/TOF. Total protein lysates of
PAO1, VE2 (PAO1 with constitutive expression of mucE)
and VE2ΔalgU (VE2 with in-frame deletion of algU)

were collected and analyzed. Within the three samples,
166 unique proteins were identified with 1455 peptides
assayed at/or above 95% confidence. The data set was
then filtered to include only proteins that were significantly different between samples and the number of the
detected peptides for each protein more than three
(Additional file 1: Table S3). By comparing the proteomes of VE2 to PAO1, the effects of increased MucE
levels on PAO1 were examined; while comparing
VE2ΔalgU to PAO1 allowed for the determination of
AlgU-independent protein production in VE2. As seen
in Additional file 1: Table S3, compared to PAO1, 11
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Figure 4 Induction of PmucE activity by cell wall stress. A. A 1/200 dilution of the PAO1::attB::PmucE-lacZ recombinant strain grown overnight
was inoculated into LB media containing X-gal and the agents listed as follows, 1) LB (control), 2) triclosan 25 μg/ml, 3) tween-20 0.20% (v/v), 4)
hydrogen peroxide 0.15%, 5) bleach 0.03%, 6) SDS 0.10%, 7) ceftazidimine 2.5 μg/ml, 8) tobramycin 2.5 μg/ml, 9) gentamicin 2.5 μg/ml, 10)
colisitin 2.5 μg/ml, and 11) amikacin 2.5 μg/ml. B. Triclosan, SDS, and ceftazidimine were tested for the induction of the PmucE and PalgU promoters.
The activities of the promoter fusions were measured by β-galactosidase activity as described in Methods.

proteins were differentially expressed due to mucE overexpression, and two of them (elongation factor Tu and
transcriptional regulator MvaT) are AlgU-independent.

Discussion
MucE is a small envelope protein whose overexpression
can promote alginate overproduction in P. aeruginosa
strains with a wild type MucA [9]. Here, we observed
that AlgU can induce the expression from PmucE, and
consistent with this result, the PmucE activity is higher in
mucoid strains than in non-mucoid strains (Figure 3).
AlgU is a stress-related alternate sigma factor that is
auto-regulated from its multiple promoters [25]. As a
sigma factor, AlgU drives transcription of the alginate
biosynthetic gene algD [5] and the alginate regulator
gene algR [26]. As shown in this study, AlgU can also
activate the transcription of mucE, and subsequently, depending on the level of induction, MucE can increase
PalgU and PalgD activity resulting in mucoid conversion
in clinical strains. Together, these results suggest a positive feedback mechanism of action in which AlgU activates mucE expression at the PmucE promoter, and in
return, the increased level of MucE can increase AlgU
activity by activating AlgW, which further degrades
MucA (Figure 7). This regulation between MucE and
AlgU probably ensures that a cell, upon exposure to
stress, can rapidly reach the desired level of AlgU and alginate production. Therefore, it is not surprising to see

that a higher level of alginate production requires mucE in
P. aeruginosa strains with a wild type MucA (Additional
file 1: Figure S2). We also noted that some cell wall stress
agents, like triclosan and SDS can induce the expression
of mucE. However, the differential activation at PalgU by
triclosan but not SDS suggests SDS may not be an inducer
at PalgU, and/or the stimulation by SDS was not high
enough to initiate the positive feedback regulation of
MucE by AlgU. Nevertheless, this observation is consistent with what was previously reported by Wood et al. regarding the absence of induction at PalgD by SDS [27].
Furthermore, we found that strain PAO1 does not become
mucoid when cultured on LB or PIA plates supplemented
with triclosan or SDS at the concentration as used in
Figure 4 (data not shown).
Qiu et al. have reported that MucE can induce alginate
overproduction when over-expressed in vivo [9]. However, nothing was known about the regulation of mucE.
Recently, the genome-wide transcriptional start sites of
many genes were mapped by RNA-seq in P. aeruginosa
strain PA14 [28]. However, the transcriptional start site
of the mucE gene (PA14_11670) was not included. In
this study, we reported the mapping of the mucE transcriptional start site. Furthermore, we found the transcription of mucE is dependent on AlgU. Analysis of the
upstream region of mucE reveals an AlgU promoter-like
sequence (Figure 1). Previously, Firoved et al. identified
35 genes in the AlgU regulon, based on scanning for
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Figure 5 MucE-mediated mucoid conversion in nonmucoid clinical isolates is dependent on MucA length and algU genotype. The
length of MucA is shown with two functional domains as depicted with RseA_N and RseA_C, which represent the N-terminal domain of MucA
predicted to interact with AlgU in the cytoplasm and C-terminal domain of MucA located in the periplasm, respectively. The domain prediction is
based on the NCBI Conserved Domain Database (CDD). The blue vertical line represents the truncated MucA due to the mutation from each CF
strain relative to the full length of wild type MucA. The type of AlgU is indicated for each CF strain (WT or mutant with the indicated change of
amino acid due to missense mutation). Those strains that become mucoid upon mucE induction are shown in red, while those that remain
nonmucoid are shown in black. The red arrow indicates the cutting site of MucA by AlgW. pHERD20T-mucE was conjugated into these non-mucoid
CF isolates, and then incubated on PIA plates containing carbenicillin and 0.1% L-arabinose at 37°C for 24 hours. Mucoid or non-mucoid phenotype
was scored based on visual inspection and the amount of alginate production. The quantity of alginate was measured and shown in Table S2.

AlgU promoter consensus sequence (GAACTTN16-17
TCtgA) in the PAO1 genome [26]. In this study, we
found that AlgU can activate the transcription of mucE.
In order to determine whether AlgU can bind to PmucE
region, AlgU was purified (Additional file 1: Figure S3)
and electrophoretic mobility shift assay (EMSA) was

performed. As seen in Additional file 1: Figure S4, our
results showed that AlgU affected the mobility of PmucE
DNA, especially in the presence of E. coli RNA polymerase core enzyme, suggesting a direct binding of AlgU to
PmucE. However, whether small regulatory RNAs or other
unknown regulator proteins are also involved in the

Figure 6 AlgU with missense mutations induces decreased amount of alginate compared to wild type AlgU. PAO1, CF149 and CF28
algUs were cloned into pHERD20T vector, and conjugated into PAO1ΔalgU and PAO1miniCTX-PalgD-lacZ, respectively. Alginate production
(μg/ml/OD600) and PalgD activity were measured after culture overnight on PIA plates supplemented with 300 μg/ml of carbenicillin. The values
reported here represent an average of three independent experiments with standard error.
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Figure 7 Schematic diagram summarizing the positive feedback between MucE and AlgU and their relationship to alginate overproduction.
AlgU is an alternative sigma factor that controls the alginate biosynthetic operon. Additionally, AlgU regulates itself, as well as drives transcription of
mucE. MucE has the C-terminal –WVF motif that can activate the protease AlgW, thereby causing the degradation of the anti-sigma factor MucA. The
degradation of MucA results in the release of AlgU to activate transcription at the PalgU, PalgD and PmucE promoter sites.

transcriptional regulation of mucE needs further study.
LptF is another example of an AlgU-dependent gene, but
doesn’t have the consensus sequence in the promoter region [29]. While MucE, as a small envelope protein is
positively regulated through a feedback mechanism, it’s
not clear how many AlgU-regulated genes follow the same
pattern of regulation as MucE.
The mucA mutation is a major mechanism for the
conversion to mucoidy. Mutation can occur throughout
the mucA gene (585 bps) [30]. These mutations result in
the generation of MucA proteins of different sizes. For
example, unlike the wild type MucA with 194 amino
acid residues, MucA25, which is produced due to a
frameshift mutation, results in a protein containing the
N-terminal 59 amino acids of MucA, fused with a
stretch of 35 amino acids without homology to any
known protein sequence [31]. MucA25 lacks the transmembrane domain of wild type MucA, predicting a
cytoplasmic localization. Therefore, different mucA mutations could possibly result in different cellular compartment localization. Identification of MucE’s function
as an inducer of alginate in strains with wild type MucA
and AlgU strongly suggests MucE acts through interaction with AlgW in the periplasm. On the other hand,
the loss of this predicted MucA-AlgW interaction can
be seen in two strains, CF11 and CF28, which lack the
major cleavage site of AlgW [32] (Figure 5). Interestingly,

we observed that the missense mutation in algU can reduce, but not completely abolish, the activity of AlgU as
an activator for alginate production. This data may explain
why mutant algU alleles have reduced PmucE activity
(Figure 2). Furthermore, since AlgU is an auto-regulated
protein [25], this may explain why the PmucE activity induced by mutant AlgU is lower than that of wild type
AlgU. A slightly higher activity of PmucE noted in CF149
(+algU) than in PAO1VE1 (Figure 3A) could be due to a
combined effect of dual mutation of algU and mucA in
CF149. In strains of FRD2 and CF14, the retention of
the AlgW cleavage site is not sufficient to restore
mucoidy. This is because of the partial function of AlgU,
which can be seen with alginate production and AlgUdependent PalgD promoter activity (Figure 6). Altogether,
these results suggest that mucoidy in clinical isolates can
be modulated by a combination of two factors, the size
of the MucA protein and the genotype of the algU allele
in a particular strain. MucA size determines its cellular
localization and its ability to sequester AlgU, and the
algU allele determines whether AlgU is fully or partially
active.
The iTRAQ results showed that the expression of two
proteins was significantly increased and the expression
of nine proteins was decreased in the mucE overexpressed strain VE2 (Additional file 1: Table S3). Of
these 11 proteins, nine of them are AlgU dependent, for
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including flagellin type B. Garrett et al. previously reported that AlgU can negatively regulate flagellin type B
and repress flagella expression [33]. However, no AlgU
consensus promoter sequences were found within the upstream of the 11 regulated genes through bioinformatics
analysis, indicating that these may be indirect effect. In
addition, two proteins (elongation factor Tu and transcriptional regulator MvaT) were significantly decreased when
compared to PAO1 proteome, but remained unchanged
when comparison was made between VE2 and VE2ΔalgU,
suggesting the reduction of these two proteins was independent of AlgU in the MucE over-expressed strain. MvaT
is a global regulator of virulence in P. aeruginosa [34],
and elongation factor Tu is important for growth and
translation. Elongation factor Tu has also been shown to
act as a chaperone in E. coli, consistent with induction of
proteins involved in responding to heat or other protein
damaging stresses [35]. Recently, elongation factor Tu has
been shown to have a unique post-translational modification that has roles in colonization of the respiratory tract
[36,37]. The differential expression of Tu due to mucE
overexpression suggests there may be signaling networks
dependent upon mucE that we have not yet been identified.
Although, previous studies have shown that the growth
rate is slower in mucoid strains and the virulence is increased after deleting AlgU [15,38], the relationship between MucE and growth or virulence need further study.
Together, iTRAQ analysis suggests that MucE signaling
affected both AlgU-dependent and AlgU-independent
protein expression.

Conclusions
The alternative sigma factor AlgU was responsible for
mucE transcription. Together, our results suggest there
is a positive feedback regulation of MucE by AlgU in P.
aeruginosa, and the expression of mucE can be induced
by exposure to certain cell wall stress agents, suggesting
that mucE may be part of the signal transduction that
senses the cell wall stress to P. aeruginosa.
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